| |
| |
|
| Insider
Information: |
Falberg Kathryn E |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
909,461 |
|
|
Indirect Shares
|
402,106 |
|
|
| Direct
Value |
$49,942,943 |
|
|
|
Indirect Value
|
$8,429,248 |
|
|
| Total
Shares |
1,311,567 |
|
|
| Total
Value |
$58,372,192 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 48.2%
|
 -87.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2016-05-04 |
358,253 |
2007-05-15 |
0 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
CFO and COO |
2009-06-16 |
0 |
|
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
EVP and CFO |
2014-03-05 |
133,387 |
2012-08-16 |
0 |
Premium* |
|
|
Medivation Inc |
MDVN |
Director |
2016-09-28 |
0 |
2016-09-28 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2015-05-06 |
12,572 |
|
0 |
Premium* |
|
|
Aimmune Therapeutics, Inc. |
AIMT |
Director |
2020-10-13 |
0 |
2020-10-10 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2016-07-15 |
2,640 |
2016-07-15 |
0 |
Premium* |
|
|
Trade Desk, Inc. |
TTD |
Director |
2024-03-08 |
242,609 |
2024-03-08 |
50,000 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
Director |
2017-04-17 |
53,937 |
2017-04-17 |
0 |
Premium* |
|
|
Arcus Biosciences Inc |
RCUS |
Director |
2023-06-15 |
46,900 |
2023-06-15 |
102,106 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
Director |
2021-06-10 |
59,163 |
2018-07-02 |
0 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2022-11-30 |
0 |
2022-12-05 |
250,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2024-03-08 |
4 |
S |
$81.90 |
$8,438,201 |
D/D |
(103,030) |
242,609 |
0 |
% |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2024-03-08 |
4 |
OE |
$1.80 |
$185,763 |
D/D |
103,030 |
345,639 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
6,800 |
46,900 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2023-06-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,504 |
40,100 |
0 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$99,907 |
D/D |
5,836 |
242,609 |
0 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2023-02-06 |
4 |
D |
$59.83 |
$1,256 |
D/D |
(21) |
236,752 |
0 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2022-12-05 |
4 |
B |
$1.95 |
$83,962 |
I/I |
43,000 |
250,000 |
2.1 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2022-12-02 |
4 |
B |
$1.98 |
$93,187 |
I/I |
47,000 |
207,000 |
2.1 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2022-12-01 |
4 |
B |
$1.97 |
$167,599 |
I/I |
84,959 |
160,000 |
2.1 |
- |
|
| NUVB |
Nuvation Bio Ord Shs Clas... |
Director |
– • – |
2022-11-30 |
4 |
B |
$1.85 |
$139,088 |
I/I |
75,041 |
75,041 |
2.1 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,100 |
90,604 |
0 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$70,899 |
D/D |
5,363 |
236,773 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,403 |
59,163 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
86,504 |
0 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2021-05-27 |
4 |
A |
$0.00 |
$70,362 |
D/D |
500 |
3,141 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2021-03-31 |
4 |
B |
$28.35 |
$566,996 |
I/I |
20,000 |
102,106 |
2.1 |
% |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2020-11-19 |
4 |
S |
$806.63 |
$16,263,340 |
D/D |
(20,000) |
2,641 |
0 |
% |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
22,641 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-13 |
4 |
D |
$34.50 |
$270,480 |
D/D |
(7,840) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$2,411,343 |
I/I |
(69,894) |
0 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-10-10 |
4 |
D |
$34.50 |
$2,249,124 |
D/D |
(65,192) |
0 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
Director |
– • – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,670 |
42,760 |
0 |
- |
|
| RCUS |
Arcus Biosciences Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
83,504 |
0 |
- |
|
| AIMT |
Aimmune Therapeutics, Inc... |
Director |
– • – |
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,840 |
73,032 |
0 |
- |
|
| TTD |
Trade Desk, Inc. |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$65,910 |
D/D |
1,165 |
2,641 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
